Siemens Healthineers Science & Innovation Days

Siemens Healthineers Science & Innovation Days
 
Kontakt

From Tuesday, April 25 to Thursday, April 27, we also offer Atellica™ Portfolio Instrument Demonstrations during lunch break as well as before and after the sessions.


Monday, April 24, 2017

09:00 a.m. - 12:00 noonArrival and Registration
12:00 noon – 01:00 p.m.Lunch
01:00 p.m. – 02:00 p.m.Welcome
02:00 p.m. – 05:30 p.m.Atellica™ Portfolio Roadshow
06:00 p.m.Evening Reception at Sheraton Hotel

 



Tuesday, April 25, 2017

09:00 a.m. – 09:30 a.m.       Opening
Franz Walt, President of Laboratory Diagnostics
09:30 a.m. – 10:30 a.m.Session 1: Cardiac Care
Chair: Prof. Dr. Allan Jaffe, Mayo, Rochester, USA
  
•   Troponin I – Lab Perspective
       Prof. Dr. Rob Christenson, Baltimore, USA
10:30 a.m. – 11:00 a.m.Break
11:00 a.m. – 12:30 p.m.Session 1: Cardiac Care (continued)
Chair: Prof. Dr. Allan Jaffe, Mayo, Rochster, USA
  
•   Troponin I – Clinical Perspective
       Prof. Dr. Paul Collinson, London, UK
  
•   Panel Discussion
12:30 p.m. – 02:00 p.m.Lunch
In parallel: Atellica™ Portfolio Instrument Demonstrations
02:00 p.m. – 03:30 p.m.

Session 2: Kidney Disease
Chair: Prof. Dr. Elke Schäffner

   •   Acute Kidney Failure: The CSA-NGAL score for
       monitoring acute tabular damage associated with
       cardiac surgery
       Dr. Hilde R. H. de Geus, Erasmus, Rotterdam, NL

   •   Chronic Kidney Disease: Importance of estimating
       eGFR in the elderly – data from Berlin Initiative
       Study (BIS)
       Dr. Natalie Ebert, Charité, Berlin Germany

03:30 p.m. – 04:00 p.m.Break
04:00 p.m. – 05:30 p.m.Session 2: Kidney Disease (continued)
Chair: Prof. Dr. Elke Schäffner

   •   End-stage renal disease (ESRD): How Beta-Trace
       Protein can help to manage dialysis patients more
       efficiently
       Dr. Tariq Shafi, Johns Hopkins, Baltimore, USA

05:30 p.m. – 06:00 p.m.Atellica™ Portfolio Instrument Demonstrations
07:00 p.m.Dinner

 



Wednesday, April 26, 2017

08:30 a.m. – 08:50 a.m.        Atellica™ Portfolio Instrument Demonstrations
09:00 a.m. – 10:30 a.m.Session 3: Hemostasis
Chair: Dr. Jürgen Koscielny

   •   Antithrombotic Therapy: What is new in the
       2016 guideline update? Options for Laboratory Testing
       Prof. Dr. Michael Spannagl, Munich, Germany

   •   Anticoagulant Therapy and Impact on Coagulation
       Activation (F1+2, D-Dimer)
       Dr. Veronique Le Cam-Duchez, Rouen, France
10:30 a.m. – 11:00 a.m.Break
11:00 a.m. – 12:30 p.m.Session 3: Hemostasis (continued)
Chair: Dr. Jürgen Koscielny

   •   PFA and von Willebrand Factor Multimers for Prediction
       of Complications with Aortic Valve Replacement
       Prof. Dr. Sophie Susen, CHRU Lille, France

   •   Disseminated Intravascular Coagulopathy – a severe
       Complication in Medical Emergencies and Sepsis
       Prof. Dr. Bernd Jilma, AKH Vienna, Austria
12:30 p.m. – 02:00 p.m.Lunch
In parallel: Atellica™ Portfolio Instrument Demonstrations
 
02:00 p.m. – 03:30 p.m.Session 4: Sepsis; Inflammation
Chair: Prof. Dr. Frank Brunkhorst

   •   Strengths and Limitations of Procalcitonin
       Prof. Dr. Pierre Hausfater, Paris, France

   •   Overview on Diagnostic Relevance of CSF – IL-6
       Dr. Peter Fraunberger, Feldkirch, Austria
03:30 p.m. – 04:00 p.m.Break
04:00 p.m. – 05:00 p.m.Session 5: Infectious Disease
   •   The role of Hepatitis B Virus Surface Antigen
       Quantification
       Dr. Jens Verheyen, Kaiserslautern, Germany
05:00 p.m. – 05:30 p.m.Atellica™ Portfolio Instrument Demonstrations
07:00 p.m.Dinner

 



Thursday, April 27, 2017

08:30 a.m. – 08:50 a.m.        Atellica™ Portfolio Instrument Demonstrations
09:00 a.m. – 10:30 a.m.Session 6: ELF™
Chair: Prof. Dr. William Rosenberg

   •   The value of ELF™ in the diagnose of NAFLD/NASH
       or Serum biomarkers for risk stratification in
       non-alcoholic fatty liver disease
       Prof. Elizabeth Powell, Australia

   •   The Diagnostic Performance of Alcohol-related
       Liver Disease Serum Markers
       Dr. Julie Parkes, Southampton, UK
10:30 a.m. – 11:00 a.m.Break
11:00 a.m. – 12:30 p.m.Session 7: TSI
Chair: Prof. Dr. Hossein Sadrzadeh

   •   TSI: Is it a better test for Graves Disease?
        Prof. Dr. Hossein Sadrzadeh, Calgary, Canada

   •   TSI: Clinical perspective
        Prof. Dr. Matthias Schott, Duesseldorf, Germany

12:30 p.m. – 02:00 p.m.Lunch
In parallel: Atellica™ Portfolio Instrument Demonstrations
02:00 p.m. – 04:00 p.m.Session 8: Syva
   •   Drug Testing
       Dr. Raymond J. M. Niesink, Netherlands
   •   E. R. Access by acute intoxication of psychoactive
       substances: trend 2012 - 2016
       Dr. Carlo A. Locatelli, Pavia, Italy
04:00 p.m. – 04:30 p.m.Atellica™ Portfolio Instrument Demonstrations
04:30 p.m.End of Meeting

 



Share this page: